Author:
Xu Xiaoliang,Yin Yin,Tang Junwei,Xie Yu,Han Zhuo,Zhang Xudong,Liu Qiaoyu,Qin Xihu,Huang Xinli,Sun Beicheng
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference32 articles.
1. Margini C, Dufour JF . The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment. Liver Int 2016; 36: 317–324.
2. Razumilava N, Gores GJ . Sorafenib for HCC: a pragmatic perspective. Oncology 2011; 25: 300, 302.
3. Cai L, Wang GJ, Xu ZL, Deng DX, Chakrabarti S, Cherian MG . Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. Anticancer Res 1998; 18: 4667–4672.
4. Cao W, Li J, Hu C, Shen J, Liu X, Xu Y et al. Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China. Support Care Cancer 2013; 21: 475–483.
5. Greten TF, Wang XW, Korangy F . Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches. Gut 2015; 64: 842–848.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献